339 related articles for article (PubMed ID: 17877509)
1. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
[TBL] [Abstract][Full Text] [Related]
2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
3. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
4. DLG5 variants in inflammatory bowel disease.
Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
[TBL] [Abstract][Full Text] [Related]
5. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
6. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
7. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
[TBL] [Abstract][Full Text] [Related]
8. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
9. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
[TBL] [Abstract][Full Text] [Related]
10. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
11. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
[TBL] [Abstract][Full Text] [Related]
12. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
[TBL] [Abstract][Full Text] [Related]
13. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
14. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
15. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
[TBL] [Abstract][Full Text] [Related]
16. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
[TBL] [Abstract][Full Text] [Related]
17. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
18. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease.
Jess T; Riis L; Jespersgaard C; Hougs L; Andersen PS; Orholm MK; Binder V; Munkholm P
Am J Gastroenterol; 2005 Nov; 100(11):2486-92. PubMed ID: 16279904
[TBL] [Abstract][Full Text] [Related]
19. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
20. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
